Whole-brain histogram analysis and top 20% gray and white matter ratio of amyloid positron emission tomography: A comparison with the centiloid scale
Abstract Objective To compare whole-brain histogram analysis (WBHA) of amyloid-β (Aβ) positron emission tomography (PET) using several magnetic resonance imaging (MRI)-based brain extraction (brain extraction tool [BET]) methods, to evaluate a novel quantitative analysis method, namely the Top 20% Gray and White Matter Ratio (GW-ratio), to determine appropriate thresholds, and to evaluate diagnostic performance in comparison with the Centiloid scale (CL). Methods We analyzed structural MRI, 18 F-flutemetamol amyloid PET images, and dementia severity scores (Global Clinical Dementia Rating [G-CDR] and Mini-Mental State Examination [MMSE]) of 262 participants. For WBHA, BET was performed using structural MRI and three different BET software programs, namely High-Definition-BET (HD-BET), FMRIB Software Library (FSL), and Statistical Parametric Mapping (SPM). Skewness and mode-to-mean ratio (MMR) were measured using brain-extracted PET. The Top 20% Map was generated from SPM BET images, separated into gray and white matter voxels, and their ratio was calculated as the GW-ratio. The CL value was computed using structural MRI. Aβ-negativity or positivity was visually determined. Results Skewness from three BET methods was strongly negatively correlated with CL. Skewness (HD-BET) showed the strongest correlation (R = -0.9043). Moreover, the GW-ratio strongly correlated with CL (R = 0.8332), whereas MMR, particularly MMR (FSL) (R = 0.2112), showed poor correlation. All indicators significantly distinguished Aβ-negative from Aβ-positive visuals. CL had the highest area under the curve (AUC, 0.9959), followed by skewness (HD-BET) (0.9927), Top 20% GW-ratio (0.9872), and skewness (SPM) (0.9779), with no statistical difference between CL and skewness (HD-BET) ( P = 0.5763). Based on mean and SD values from 118 cognitively unimpaired (G-CDR = 0, MMSE ≥ 28) and visually Aβ-negative participants, 95% cut-off limits for Aβ-negative individuals without dementia symptoms were: CL ≤ 12.9, skewness (HD-BET) ≥ 0.1769, MMR (HD-BET) ≤ 0.9372, skewness (FSL) ≥ 0.1819, MMR (FSL) ≤ 1.9132, skewness (SPM) ≥ -0.0382, MMR (SPM) ≤ 1.1274, and GW-ratio ≤ 0.1079. Conclusion WBHA using MRI-based BET and GW-ratio showed strong correlations with CL and demonstrated a diagnostic performance comparable to that of CL.
Authors
- Ayaka Nemoto
- Yoshie Omachi
- Shigeyasu Sugawara (ORCID: https://orcid.org/0000-0002-8795-8099)
- Takashi Hanakawa (ORCID: https://orcid.org/0000-0003-3267-8214)
- Hiroyasu Ikeno (ORCID: https://orcid.org/0000-0002-7582-5117)
- Kazuaki Sajima
- Masanori Sawamura (ORCID: https://orcid.org/0000-0002-9613-6230)
- Jun Tazoe
- Yosuke Taruno
- Etsuro Nakanishi (ORCID: https://orcid.org/0009-0006-9869-4988)
- Hideaki Takasumi (ORCID: https://orcid.org/0000-0001-6333-0056)
- Harumasa Takano (ORCID: https://orcid.org/0000-0001-8492-1533)
- Yuji Takahashi (ORCID: https://orcid.org/0000-0001-5335-7757)
- Takeshi Nii (ORCID: https://orcid.org/0000-0003-0409-8378)
- Tomohisa Okada (ORCID: https://orcid.org/0000-0003-2312-5677)
- Atsushi Shima (ORCID: https://orcid.org/0000-0002-3068-4621)
- Shiho Ubukata (ORCID: https://orcid.org/0000-0002-2907-5757)
- Kentaro Akazawa (ORCID: https://orcid.org/0000-0003-3646-1821)
- Yoko Nakano (ORCID: https://orcid.org/0000-0003-1640-1979)
- Nozomu Matsuda (ORCID: https://orcid.org/0000-0003-3773-6778)
- Mitsunari Abe (ORCID: https://orcid.org/0000-0002-3913-2292)
- Fukiko Morii‐Kitani
- Kyoji Okita (ORCID: https://orcid.org/0000-0002-7189-9039)
- 福岡寛子
- Shinya Seino
- Kotaro Hattori (ORCID: https://orcid.org/0000-0002-4411-2317)
- Yasutaka Fushimi (ORCID: https://orcid.org/0000-0002-1982-3168)
- Emiya Koike
- Kiyoaki Takeda
- Hiroshi Hoshino (ORCID: https://orcid.org/0000-0001-5755-8126)
- Yayoi Kurihara
- Teruyuki Matsuoka (ORCID: https://orcid.org/0000-0001-7683-7825)
- Atsuko Inoue (ORCID: https://orcid.org/0009-0006-5869-0464)
- Nobukatsu Sawamoto (ORCID: https://orcid.org/0000-0001-8695-0223)
- Fumitoshi Niwa (ORCID: https://orcid.org/0000-0001-5431-5559)
- Noritaka Wakasugi (ORCID: https://orcid.org/0000-0003-3200-3081)
- Ryo Yamakuni (ORCID: https://orcid.org/0000-0003-0265-5636)
- Yusuke Sakato
- Kasumi Hattori
- Hiroki Togo
- Haruhi Sakamaki‐Tsukita (ORCID: https://orcid.org/0000-0001-9089-6389)
- Ikko Wada (ORCID: https://orcid.org/0009-0003-5180-6063)
- Wataru Toda
- Minoru Oto (ORCID: https://orcid.org/0009-0009-1407-2738)
- Daisuke Kambe (ORCID: https://orcid.org/0009-0006-4187-5729)
- Daisuke Goto (ORCID: https://orcid.org/0000-0003-4921-3851)
- Takashi Kasai
- Kazuaki Kanai (ORCID: https://orcid.org/0000-0002-2174-002X)
- Kenji Yoshinaga
- Toma Matsushima
- Noriko Nishikawa
- Yuta Terada
- Anna Yamaki
- Takashi Kanezawa
- Yuhei Mori
- Kazuko Kanno
- Takashi Sakamoto
- Mayumi Inoue
- Koichi Kato
- Toshiki Mizuno
- Yasuhiro Hashimoto
- Yoshiki Endo
- Yuka Ueda
- Hirooki Yabe
- Yohei Aoshima
- Tadashi Tsukamoto
- Shizuko Sugou
- Atsushi Sekiguchi
- Sinobu Kawakakatsu
- Hironobu Ishikawa
- Shinichiro Mogi
- Toshiya Murai
- Hirofumi Sekino
- Yuji Nakamoto
- Ryosuke Takahashi
- Nagara Tamaki
- Jin Narumoto
- Kenji Fukushima
- Akira Nishida
- Yuya Hagane
- Hiroshi Hayashi
- Tomoya Kotani
- Kenji Hishikawa
- Yohei Mukai
- Masaki Kondo
- Toshiki Nakahara
- Naoto Kobayashi
- Koji Furukawa
- Katuyuki Kikori
- Hiroshi Ito
- Kei Yamada
- Hodaka Yamakado
- Kenji Yoshimura
- Alzheimer’s disease Dimensional Neuroimaging Initiative (PADNI) Parkinson’s
- Naoyuki Ukon
- Shiro Ishii
Institutions
- Fukushima Medical University (JP)
- Kyoto University (JP)
- Kyoto Prefectural University of Medicine (JP)
- National Cancer Centre Japan (JP)
- Fukushima Medical University Hospital (JP)
Publication Details
- Journal
- Annals of Nuclear Medicine
- Published
- 2026-05-18
- DOI
- https://doi.org/10.1007/s12149-026-02218-9
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science